Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Feedback Loops01:01

Feedback Loops

In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human factors in the use and efficacy of decision support technologies for type 1 diabetes: evidence from a randomized controlled trial.

Diabetes research and clinical practice·2025
Same author

Type 1 Diabetes Management in the Female Population: Evaluation of the Impact of Sex on Glycemic Control and the Perceived Performance of Diabetes Technology Across the Menstrual Cycle.

Diabetes spectrum : a publication of the American Diabetes Association·2025
Same author

A randomized controlled trial of a digital cognitive behavioral therapy for insomnia for older adults.

NPJ digital medicine·2025
Same author

Practical Considerations and Implementation of Automated Insulin Delivery Systems.

Journal of diabetes science and technology·2025
Same author

Practical Considerations and Implementation of Automated Insulin Delivery Systems.

Diabetes technology & therapeutics·2025
Same author

Depression and Obesity.

Current obesity reports·2025

Related Experiment Video

Updated: May 26, 2026

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Closed-loop glucose control: psychological and behavioral considerations.

Linda Gonder-Frederick1, Jaclyn Shepard, Ninoska Peterson

  • 1Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia 22908 , USA. lag3g@virginia.edu

Journal of Diabetes Science and Technology
|January 10, 2012
PubMed
Summary

Patient factors like perceptions and self-regulation are key for adopting new diabetes technology. Understanding these human elements is crucial for the success of advanced glucose control systems.

More Related Videos

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Experiment Videos

Last Updated: May 26, 2026

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

  • Endocrinology
  • Medical Technology
  • Behavioral Science

Background:

  • Diabetes management has seen significant technological advancements since 2000.
  • Closed-loop glucose control (CLC) systems represent the latest innovation, integrating continuous glucose monitoring and insulin infusion to reduce glycemic variability.
  • Despite technological progress, patient adherence to diabetes regimens and technology utilization remains challenging.

Purpose of the Study:

  • To review psychological and behavioral factors influencing the adoption and use of past diabetes technologies.
  • To examine theoretical frameworks for understanding patient factors in diabetes management.
  • To propose patient-selection criteria for future CLC systems.

Main Methods:

  • Literature review of psychological and behavioral factors in diabetes technology adoption.
  • Analysis of three theoretical frameworks relevant to patient self-regulation and adherence.
  • Development of proposed patient-selection factors for CLC systems.

Main Results:

  • Human factors, including patient perceptions and self-regulation, are critical for adherence and technology adoption.
  • Theoretical frameworks can help conceptualize these patient-specific factors.
  • Identifying appropriate patient-selection factors is essential for the successful implementation of CLC systems.

Conclusions:

  • Patient psychological and behavioral factors are central to the successful adoption and utilization of diabetes management technologies.
  • Understanding and addressing these human factors is vital for optimizing the use of advanced systems like CLC.
  • Future CLC system implementation should consider patient-selection factors informed by psychological and behavioral insights.